Abstract spiral tunnel representing data management oversight

CRO Oversight: Restoring Quality to Outsourced Oncology and Rheumatology Studies

1 minute read

Published: July 16th, 2025

After acquiring a biotech, a global pharma company faced major issues with two ongoing pharmacokinetic studies—both fully outsourced and poorly managed. Lack of CRO oversight had led to data inconsistencies, missed deadlines, and quality concerns.

Phastar was brought in to take control. By providing targeted CRO oversight, identifying critical data issues, and driving process improvements, we helped deliver an on-time database lock and restored confidence in the studies.

In the full case study, you’ll see:

  • The oversight steps taken to regain control
  • How we resolved data quality and reconciliation issues
  • The sponsor’s feedback on Phastar’s impact

Complete the form to download the full case study.

Related articles

From Rescue Study to Strategic Partnership: Accelerating Regulatory Submission Through Reliable Statistical Delivery

From Rescue Study to Strategic Partnership: Accelerating Regulatory Submission Through Reliable Statistical Delivery

November 16th, 2026 1 minute read

When clinical development programs face quality concerns, resource shortages, or submission risks, sponsors need a pa...

Turning a Failed Bioequivalence Study into a Successful Regulatory Outcome 

Turning a Failed Bioequivalence Study into a Successful Regulatory Outcome 

November 16th, 2026 1 minute read

When a bioequivalence study fails to meet regulatory criteria, understanding why is critical for successful developme...

Independent DMC Support and Interim Analysis for an ALS Clinical Trial 

Independent DMC Support and Interim Analysis for an ALS Clinical Trial 

November 16th, 2026 1 minute read

Data Monitoring Committees play a vital role in safeguarding patient safety and supporting informed decision-making t...